IL175873A0 - Production of diphtheria toxin - Google Patents

Production of diphtheria toxin

Info

Publication number
IL175873A0
IL175873A0 IL175873A IL17587306A IL175873A0 IL 175873 A0 IL175873 A0 IL 175873A0 IL 175873 A IL175873 A IL 175873A IL 17587306 A IL17587306 A IL 17587306A IL 175873 A0 IL175873 A0 IL 175873A0
Authority
IL
Israel
Prior art keywords
production
diphtheria toxin
diphtheria
toxin
Prior art date
Application number
IL175873A
Other languages
English (en)
Original Assignee
Sanofi Pasteur Ltd
Lee Tim
Xu Xuefeng
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Pasteur Ltd, Lee Tim, Xu Xuefeng filed Critical Sanofi Pasteur Ltd
Publication of IL175873A0 publication Critical patent/IL175873A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/34—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL175873A 2003-12-12 2006-05-23 Production of diphtheria toxin IL175873A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48178003P 2003-12-12 2003-12-12
PCT/CA2004/002024 WO2005056773A1 (en) 2003-12-12 2004-11-30 Production of diphtheria toxin

Publications (1)

Publication Number Publication Date
IL175873A0 true IL175873A0 (en) 2006-10-05

Family

ID=34676553

Family Applications (1)

Application Number Title Priority Date Filing Date
IL175873A IL175873A0 (en) 2003-12-12 2006-05-23 Production of diphtheria toxin

Country Status (12)

Country Link
US (1) US20110097359A1 (https=)
EP (1) EP1692269A4 (https=)
JP (1) JP2007513613A (https=)
KR (1) KR20060133994A (https=)
CN (1) CN1894399A (https=)
AU (1) AU2004297299A1 (https=)
BR (1) BRPI0417076A (https=)
CA (1) CA2546769A1 (https=)
IL (1) IL175873A0 (https=)
MX (1) MXPA06006630A (https=)
WO (1) WO2005056773A1 (https=)
ZA (1) ZA200604772B (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006042542A2 (en) * 2004-10-19 2006-04-27 Statens Serum Institut Production of tetanus, diphtheria, and pertussis toxins and toxoids using fermentation media containing no components of animal or soy origin
US7375188B2 (en) * 2005-07-29 2008-05-20 Mallinckrodt Baker, Inc. Vegetarian protein a preparation and methods thereof
RS51999B (sr) * 2008-08-28 2012-04-30 Novartis Ag Dobijanje skvalena iz hiperprodukcijskih kvasaca
CN101503725B (zh) * 2009-03-19 2012-06-06 浙江天元生物药业有限公司 一种用于提高白喉类毒素纯度的工艺
AU2010201410B2 (en) * 2010-03-30 2015-04-30 Pelican Technology Holdings, Inc. High level expression of recombinant CRM197
EP2553102B1 (en) 2010-03-30 2015-12-09 Pfenex Inc. High level expression of recombinant toxin proteins
DE102011118371B4 (de) 2011-11-11 2014-02-13 Novartis Ag Zur Impfung von Menschen geeignete Zusammensetzung, die ein Diphtherie-Toxoid umfasst, sowie Verfahren zu deren Herstellung
DE102011122891B4 (de) 2011-11-11 2014-12-24 Novartis Ag Fermentationsmedium, das frei von tierischen Bestandteilen ist, zur Herstellung von Diphtherie-Toxoiden zur Verwendung bei der Impfung von Menschen
EP2592137A1 (en) 2011-11-11 2013-05-15 Novartis AG Fermentation media free of animal-derived components for production of diphtheria toxoids suitable for human vaccine use
GB2495341B (en) * 2011-11-11 2013-09-18 Novartis Ag Fermentation methods and their products
AU2013203663B2 (en) * 2011-11-11 2015-05-28 Novartis Ag Fermentation media free of animal-derived components for production of diphtheria toxoids suitable for human vaccine use
CN102766647A (zh) * 2012-07-25 2012-11-07 天津康希诺生物技术有限公司 在白喉杆菌中稳定复制的表达载体及含该载体的白喉杆菌
US10905146B2 (en) * 2013-07-12 2021-02-02 The Coca-Cola Company Compositions for improving rebaudioside M solubility
CN104027797B (zh) * 2014-06-19 2015-08-26 山东亦度生物技术有限公司 一种白喉疫苗的制备方法
CN104263678A (zh) * 2014-09-02 2015-01-07 成都欧林生物科技股份有限公司 一种白喉杆菌培养基及应用其制备白喉类毒素的方法
GB2556883A (en) * 2016-11-22 2018-06-13 Liebman Miriam Apparatus for transportation and storage of footwear
WO2018193475A2 (en) 2017-04-22 2018-10-25 Biological E Limited An improved method for high level production of crm
CN110452838B (zh) * 2019-07-18 2020-12-29 艾美卫信生物药业（浙江）有限公司 一种crm197菌种培养基、配制方法及发酵培养方法
CN114806973B (zh) * 2022-06-08 2024-02-23 艾美坚持生物制药有限公司 一种提高crm197蛋白产量的生长因子及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE372376T1 (de) * 1997-05-28 2007-09-15 Novartis Vaccines & Diagnostic Kulturmedium mit sojabohnenextrakt als aminosäuren-quelle und ohne proteinkomplexe tierischen ursprungs
US6558926B1 (en) * 1999-07-16 2003-05-06 Massachusetts Institute Of Technology Method for production of tetanus toxin using media substantially free of animal products

Also Published As

Publication number Publication date
KR20060133994A (ko) 2006-12-27
US20110097359A1 (en) 2011-04-28
JP2007513613A (ja) 2007-05-31
CN1894399A (zh) 2007-01-10
ZA200604772B (en) 2007-10-31
BRPI0417076A (pt) 2007-03-13
EP1692269A1 (en) 2006-08-23
EP1692269A4 (en) 2007-09-26
AU2004297299A1 (en) 2005-06-23
MXPA06006630A (es) 2007-04-16
WO2005056773A1 (en) 2005-06-23
CA2546769A1 (en) 2005-06-23

Similar Documents

Publication Publication Date Title
EP1687016A4 (en) GENETIC VARIANT OF DIPHTHERIC TOXIN
IL175873A0 (en) Production of diphtheria toxin
HUS1500016I1 (hu) Tiacumicin elõállítása
EP1745573A4 (en) PROCESS FOR PREPARING 2-DEOXY-BETA-L-NUCLEOSIDES
IL181587A0 (en) Production of ??-abeta
GB2393983B (en) Alternative path multilateral production/injection
AU2003903909A0 (en) Production methods
GB0518574D0 (en) Production of documents
EP1855882A4 (en) NEW MARKINGS AND MANUFACTURING METHOD THEREFOR
GB0808916D0 (en) Production of conjugates
AU2003248598A1 (en) Magnetic jewellery
GB0323090D0 (en) Novel process
GB2399248B (en) Video production
GB2398029B (en) Production of disc components
GB0307232D0 (en) Production of vanillin
GB0329439D0 (en) Production of particles
GB0202397D0 (en) Production of nanotubes
GB0319382D0 (en) Production of beverages
GB0309443D0 (en) Product production
GB2407798B (en) Production of microdots
ZA200406777B (en) Production of abalone
GB2403220B (en) Production of aldoses
GB0300673D0 (en) Mosaic production
AU2003299623A8 (en) Method of making mercaptoalkylalkyldialkoxysilanes
GB0227730D0 (en) Novel production of biocompounds